Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ureteral Neoplasms × Methotrexate × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 92 Leukemia 70 Lymphoma 52 Leukemia, Myeloid, Acute 40 Burkitt Lymphoma 36 Myelodysplastic Syndromes 32 Lymphoma, Non-Hodgkin 27 Hodgkin Disease 27 Lymphoma, Mantle-Cell 24 Leukemia, Lymphocytic, Chronic, B-Cell 23 Recurrence 21 Lymphoma, Large B-Cell, Diffuse 21 Graft vs Host Disease 21 Lymphoma, Follicular 19 Congenital Abnormalities 18 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17 Multiple Myeloma 17 Myeloproliferative Disorders 15 Leukemia, Myelomonocytic, Chronic 15 Leukemia, Myeloid, Accelerated Phase 15 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15 Lymphoma, B-Cell, Marginal Zone 14 Blast Crisis 14 Leukemia, Myeloid, Chronic-Phase 13 Lymphoma, Large-Cell, Immunoblastic 12 Hematologic Neoplasms 12 Primary Myelofibrosis 11 Lymphoma, Large-Cell, Anaplastic 11 Breast Neoplasms 11 Neoplasms, Plasma Cell 10

Interventions

Gemcitabine 5 Cisplatin 4 enfortumab vedotin 2 Ramucirumab 2 Platinum 2 Docetaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 vinflunine 1 rucaparib 1 pembrolizumab 1 eribulin 1 enzalutamide 1 dehydroftorafur 1 carotuximab 1 avelumab 1 atezolizumab 1 Standard of Care 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide 1 Mitozytrex 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Interleukin-7 1 Immunoglobulin G 1 Icrucumab 1 IMC-18F1 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡